UncategorizedBiosplice Therapeutics doses first patient in Phase 1 ovarian cancer trial – Longevity.Technology Empower Meds / December 23, 2025
UncategorizedHumacyte publishes long-term Symvess safety and efficacy data in vascular trauma – Longevity.Technology Empower Meds / December 23, 2025
UncategorizedFirst human trial shows fasting mimicking diet boosts autophagy and metabolic health – Longevity.Technology Empower Meds / December 23, 2025
UncategorizedIs your longevity startup accidentally a healthcare provider? Empower Meds / December 22, 2025
UncategorizedAnnovis launches open-label extension study for Parkinson’s patients – Longevity.Technology Empower Meds / December 22, 2025
UncategorizedProMIS Neurosciences exceeds enrollment target in PRECISE-AD Phase 1b Alzheimer’s trial – Longevity.Technology Empower Meds / December 22, 2025
UncategorizedYuva Biosciences and NorthStrive Biosciences move AI‑driven drug discovery into experimental validation phase – Longevity.Technology Empower Meds / December 22, 2025
